Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.4K Buy
1,420
+321
+29% +$7.09K ﹤0.01% 671
2026
Q1
$16.4K Hold
1,099
﹤0.01% 1228
2025
Q4
$14.6K Sell
1,099
-69
-6% -$1.02K ﹤0.01% 1156
2025
Q3
$19.4K Buy
+1,168
New +$18.8K ﹤0.01% 833

Other funds holding RXO

Salomon & Ludwin's RXO Position: Q2 2026 in Review

Salomon & Ludwin increased its RXO (RXO) stake by 29% in Q2 2026, buying an estimated $7.09K and bringing the position to 1,420 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Salomon & Ludwin first reported a position in RXO in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Salomon & Ludwin held 1,420 shares of RXO worth $39.4K as of Q2 2026.
  • Salomon & Ludwin bought 321 RXO shares in Q2 2026, an estimated $7.09K.
  • RXO made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #671 holding.
  • Salomon & Ludwin first reported a position in RXO in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.